Ninety One (UK)’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-1,190,348
Closed -$111M 312
2017
Q3
$111M Sell
1,190,348
-988,330
-45% -$105M 0.49% 66
2017
Q2
$242M Buy
2,178,678
+186,477
+9% +$19.7M 1.15% 24
2017
Q1
$196M Sell
1,992,201
-38,489
-2% -$3.67M 0.97% 33
2016
Q4
$187M Sell
2,030,690
-53,889
-3% -$4.64M 0.97% 33
2016
Q3
$176M Buy
2,084,579
+46,246
+2% +$3.88M 0.86% 44
2016
Q2
$166M Sell
2,038,333
-10,966
-0.5% -$835K 0.86% 44
2016
Q1
$146M Buy
2,049,299
+191,893
+10% +$12.9M 0.79% 46
2015
Q4
$132M Sell
1,857,406
-4,299
-0.2% -$289K 0.75% 48
2015
Q3
$114M Buy
1,861,705
+13,774
+0.7% +$963K 0.72% 53
2015
Q2
$134M Sell
1,847,931
-4,183
-0.2% -$309K 0.76% 48
2015
Q1
$142M Buy
1,852,114
+100,920
+6% +$7.23M 0.83% 41
2014
Q4
$117M Buy
+1,751,194
New +$111M 0.72% 49

Other funds holding DGX

Ninety One (UK)'s DGX Position: Q4 2017 in Review

Ninety One (UK) sold out of Quest Diagnostics (DGX) in Q4 2017, closing a stake of 1,190,348 shares — an estimated $111M sold.

Ninety One (UK) first reported a position in DGX in Q4 2014 and held it in 12 quarters. The position peaked at $242M in Q2 2017. 631 funds tracked by Wall St. Rank hold DGX as of Q4 2017.

  • Ninety One (UK) reported no remaining Quest Diagnostics position as of Q4 2017 after selling out during the quarter.
  • Ninety One (UK) sold 1,190,348 Quest Diagnostics shares in Q4 2017, an estimated $111M.
  • Ninety One (UK) first reported a position in Quest Diagnostics in Q4 2014 and held it in 12 quarters.
  • Ninety One (UK)'s Quest Diagnostics position peaked at $242M in Q2 2017.
  • 631 funds tracked by Wall St. Rank held Quest Diagnostics as of Q4 2017.

Based on Ninety One (UK)'s 13F filing for Q4 2017, filed 13 Feb 2018.